Table 1 Clinical and laboratorial data of sample before and after the therapeutic intervention in all patients studied.
From: Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes
Variables | Baseline | 3 months | Significance level (p) |
|---|---|---|---|
n (number) | 51 | 51 | |
Gender(M/F) | 19/32 | 19/32 | |
Age(years) | 25,3 ± 1,55 | 25,3 ± 1,55 | |
Duration of diabetes (years) | 11,31 ± 1,09 | 11,31 ± 1,09 | |
BMI (kg/m2) | 22,87 ± 0,42 | 23,20 ± 0,47 | 0,51 |
sBP (mmHg) | 111,3 ± 1,96 (180,0- 90,0) | 111,24 ± 1,76 (180,0- 90,0) | 0,81 |
sDP(mmhg) | 70,24 ± 1,14 (90,0- 50,0) | 90,03 ± 10,12 (100,0- 50,0) | 0,32 |
A1c (%) | 10,40 ± 0,33 | 9,52 ± 0,32 | 0,0009 |
A1c < 7% (n pacientes) | 3 | 4 | |
Cholesterol(mg/dl) | 174,88 ± 5,58 | 169,94 ± 4,58 | 0,23 |
HDL-Cholesterol(mg/dl) LDL- Cholesterol(mg/dl) | 53,84 ± 1,94 210,58 ± 6,05 | 53,40 ± 1,91 202,72 ± 4,86 | 0,79 0,11 |
Triglycerides (mg/d) | 93,23 ± 7,60 | 104,63 ± 10,29 | 0,07 |
Fasting blood sugar FBS (mg/dl) | 180,00 ± 21,22 | 168,82 ± 14,79 | 0,73 |
Postprandial glycemia (mg/dl) | 256,78 ± 12,82 | 243,39 ± 15,92 | 0,46 |
Insulin dose/kg | 0,99 ± 0,65 | 1.05 ± 0.05 | 0,00 |
NPH insulin dose | 55,08 ± 22,34 | 55,18 ± 21,10 | 0,89 |
Rapid insulin dose | 4,42 ± 8,72 | 11,73 ± 7,04 | 0,00 |